scispace - formally typeset
K

Kenta Tsunekuni

Researcher at Osaka University

Publications -  12
Citations -  373

Kenta Tsunekuni is an academic researcher from Osaka University. The author has contributed to research in topics: Cancer & Tipiracil. The author has an hindex of 8, co-authored 12 publications receiving 282 citations.

Papers
More filters
Journal ArticleDOI

Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer

TL;DR: D-2HG levels were elevated in colorectal cancer specimens, particularly in those associated with distant metastasis, supporting the observations in vitro and implicating the contribution of D- 2HG in metastases, the major cause of death in this disease.
Journal ArticleDOI

The importance of mitochondrial folate enzymes in human colorectal cancer

TL;DR: expression of three mitochondrial folate metabolic enzymes, serine hydroxymethyl transferase (SHMT2), methylenetetrahydrofolate dehydrogenase (MTHFD2) and aldehyde dehydrogenases 1 family member L2 (ALDH1L2), were upregulated in human colorectal tumor tissues compared to normal tissues, suggesting that mitochondrial folATE metabolic enzymes could provide a potential therapeutic strategy for treating colore CT cancer.
Journal ArticleDOI

CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure

TL;DR: The data show that trifluridine (FTD) treatment is effective against CSC-like cells and might be applied as C SCs-targeting chemotherapy for tumor subtypes with high CD44 and CD133 expression.
Journal ArticleDOI

Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG-inactivating β-oxygenation pathway in colorectal cancer

TL;DR: A novel methodology to computationally analyze gene expression in colorectal cancer (CRC) is developed, and novel sets of genes that are associated with patient survival are identified, providing a strong rationale for studying this mechanism further in order to discover novel therapeutic targets for the treatment of CRC.